Knight Therapeutics Raises FY2026 Sales Guidance from C$510.000M-C$525.000M to C$540.000M-C$560.000M vs C$519.863M Est

Knight Therapeutics (TSX: GUD ) raises FY2026 sales outlook from C$510.000 million-C$525.000 million to C$540.000 million-C$560.000 million vs C$519.863 million estimate.